Libra Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Libra Therapeutics?

Libra Therapeutics has 6 investors including Yonjin Venture And Sante Ventures.

Q: How much funding has Libra Therapeutics raised to date?

Libra Therapeutics has raised obfuscated.

Overview

Libra Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Libra Therapeutics

CB Rank

53606

Libra Therapeutics is a biotechnology company.

Founded

obfuscation

Private

Series A

San Diego, California, United States

1-10

www.libratherapeutics.com/

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Key People

Isaac Veinbergs: Founder and CEO
Philip Lambert: Chief Scientific Officer

Details

Legal Name

Libra Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Isaac Veinbergs

About the Company

Libra Therapeutics is a biotechnology company focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases.

Contact Email

info@libratherapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Small Molecule Therapeutics for Neurodegenerative Diseases

Development of small molecule drugs aimed at restoring cellular balance by increasing autophagy and reducing neurotoxic protein production in neurodegenerative diseases.

Research & Development

Libra Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A
obfuscated obfuscation	Series A - Libra Therapeutics	6	obfuscated obfuscation	Boehringer Ingelheim Venture Fund, Epidarex Capital, Sante Ventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Yonjin Venture	—	Series A - Libra Therapeutics	—
Yonjin Venture	—	Series A - Libra Therapeutics	—
Yonjin Venture	—	Series A - Libra Therapeutics	—
Yonjin Venture	—	Series A - Libra Therapeutics	—
Yonjin Venture	—	Series A - Libra Therapeutics	—